Patients with depression typically exhibit elevated levels of inflammatory markers, such as C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), which can impact the functioning of the central nervous system, causing mood disorders and cognitive decline (Gavril et al., 2024). This evidence concerns the gene TNF and depressive symptom measurement.